Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

SG&A Expenses

$5.22M

Quarterly · Period ending: Jun 30, 2026 · USD

LCTX SG&A Expenses

Latest reported$5.22Mperiod endingJun 30, 2026

Latest reported$5.22Mperiod endingJun 30, 2026

LCTX Quarterly SG&A Expenses ($100.00K → $5.22M)

Quarterly SG&A Expenses

High-resolution chart · PNG

LCTX sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock SG&A Expenses — Quarterly (USD)
Period ending	SG&A Expenses (USD)
Jun 30, 2001	613,490
Mar 31, 2001	436,997
Dec 31, 2000	417,096
Sep 30, 2000	438,654
Jun 30, 2000	448,713
Mar 31, 2000	475,468
Dec 31, 1999	396,690
Sep 30, 1999	400,000
Jun 30, 1999	600,000
Mar 31, 1999	500,000
Sep 30, 1998	400,000
Jun 30, 1998	500,000
Mar 31, 1998	400,000
Dec 31, 1997	400,000
Sep 30, 1997	500,000
Jun 30, 1997	400,000
Mar 31, 1997	200,000
Dec 31, 1996	300,000
Sep 30, 1996	300,000
Jun 30, 1996	0
Mar 31, 1996	0
Dec 31, 1995	0
Sep 30, 1995	100,000
Jun 30, 1995	200,000
Mar 31, 1995	200,000
Dec 31, 1994	200,000
Sep 30, 1994	200,000
Jun 30, 1994	300,000
Mar 31, 1994	200,000
Dec 31, 1993	200,000
Sep 30, 1993	200,000
Jun 30, 1993	200,000
Mar 31, 1993	200,000
Dec 31, 1992	200,000
Sep 30, 1992	200,000
Jun 30, 1992	200,000
Mar 31, 1992	100,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.